Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220006658 220002561 null 52.1 Curative (C) 2014-08-12 2014-08-18 AML MyeChild 01 A Mitozantrone/Cytarabine + GO N N 220030754 NOT MATCHED
220006659 220002562 null 63.5 Curative (C) 2015-04-27 2015-04-27 AML 19 TRIAL N N 220030755 AML19 TRIAL
220006660 220002563 1.57 30.45 Curative (C) 2017-01-16 2017-01-16 AML MyeChild 01 IT Cyt 1 N 220030759 NOT MATCHED
220006661 220002563 null null Curative (C) 2015-09-29 2015-09-30 Nilotinib 2 N 220030759 NILOTINIB
220006664 220020382 1.72 null Curative (C) 2014-08-26 2014-08-28 Nilotinib N N 220030764 NILOTINIB
220006665 220021259 1.72 66.2 Curative (C) 2013-05-10 2013-05-19 AML 19 TRIAL Y N 220030766 AML19 TRIAL
220006666 220021259 1.03 77 Curative (C) 2016-10-10 2016-10-10 AML MyeChild 01 A Mitozantrone/Cytarabine + GO N N 220030766 NOT MATCHED
220006667 220021259 1.64 null Disease modification (D) 2016-03-02 2016-03-02 Nilotinib N N 220030766 NILOTINIB
220006668 220002564 0 0 Radical (R) 2017-03-17 2017-03-18 Nilotinib N N 220030775 NILOTINIB
220006669 220002564 1.83 58.3 Curative (C) 2015-08-03 2015-08-03 AML 19 TRIAL 1 N 220030775 AML19 TRIAL
220006670 220016175 0 null Unknown (U) 2014-12-19 2014-12-19 Nilotinib 2 N 220030778 NILOTINIB
220006671 220016175 null 81.9 Curative (C) 2015-08-11 2015-08-14 AML 19 TRIAL 01 Y 220030778 AML19 TRIAL
220006672 220016175 null 67 Curative (C) 2017-07-30 2017-08-08 FLAG + Idarubicin N N 220030778 FLAG + IDARUBICIN
220006673 220002565 0 46.2 Curative (C) 2016-01-04 2016-01-04 ALL Ph+ve Imatinib - Int Maint N N 220030782 NOT MATCHED
220006674 220002566 1.74 107 Curative (C) 2015-03-11 2015-03-11 AML 19 TRIAL Y N 220030783 AML19 TRIAL
220006675 220002566 1.51 51.1 Disease modification (D) 2017-02-25 2017-03-30 FLAG + Idarubicin null null 220030783 FLAG + IDARUBICIN
220006676 220002567 1.79 null Curative (C) 2015-09-20 2015-09-23 AML MyeChild 01 A Mitozantrone/Cytarabine + GO N N 220030785 NOT MATCHED
220006677 220002568 1.75 5.8 Curative (C) 2013-04-25 2013-04-25 AML Relapsed FLA - Idarubicin N N 220030791 NOT MATCHED
220006679 220011483 null null Palliative (P) 2014-07-11 2014-07-11 Nilotinib N N 220030798 NILOTINIB
220006680 220002570 1.83 77.5 Curative (C) 2016-06-10 2016-06-10 AML 19 TRIAL 1 N 220030801 AML19 TRIAL
220006681 220011484 1.55 56.8 Curative (C) null 2014-07-25 AML 19 TRIAL Y N 220030802 AML19 TRIAL
220006682 220002571 1.8 118 Curative (C) 2016-01-06 2016-01-07 AML 19 TRIAL Y N 220030803 AML19 TRIAL
220006683 220011485 0 0 Palliative (P) null 2014-04-11 Nilotinib 2 N 220030807 NILOTINIB
220006684 220011485 null null Curative (C) 2015-08-19 2015-08-22 Nilotinib N N 220030807 NILOTINIB
220006685 220011485 1.6 54.8 Curative (C) 2017-02-22 2017-02-27 FLAG + Idarubicin N N 220030807 FLAG + IDARUBICIN
220006686 220011485 0 null Curative (C) 2014-09-02 2014-09-03 Nilotinib 02 null 220030807 NILOTINIB
220006687 220002572 1.8 57.8 Curative (C) 2017-02-18 2017-02-20 AML 19 TRIAL 01 N 220030811 AML19 TRIAL
220006688 220002573 1.78 12.2 Palliative (P) 2015-11-02 2016-04-09 AML MyeChild 01 A Mitozantrone/Cytarabine N N 220030813 NOT MATCHED
220006689 220002573 1.6 68 Curative (C) 2016-12-24 2017-03-06 FLAG + Idarubicin null null 220030813 FLAG + IDARUBICIN
220006690 220002573 0 78.3 Curative (C) 2016-03-22 2016-03-26 Nilotinib 2 N 220030813 NILOTINIB
220006691 220002573 0 null Curative (C) 2016-05-24 2016-05-24 Nilotinib N N 220030813 NILOTINIB
220006692 220002573 1.64 86.1 Curative (C) 2014-08-15 2014-08-28 AML 19 TRIAL Y N 220030813 AML19 TRIAL
220006693 220002573 1.78 77.4 Curative (C) 2016-11-20 2016-11-23 AML 19 TRIAL 1 N 220030813 AML19 TRIAL
220006694 220002574 1.75 null null 2013-07-15 2013-07-15 Nilotinib 2 N 220030823 NILOTINIB
220006695 220002575 1.68 60.8 Curative (C) 2017-09-14 2017-09-14 AML 19 TRIAL 1 N 220030825 AML19 TRIAL
220006696 220002575 1.73 52.1 Curative (C) 2017-05-21 2017-06-12 AML Interim Guidelines N N 220030825 NOT MATCHED
220006697 220002576 1.66 68 Curative (C) 2014-09-26 2014-09-28 FLAG + Idarubicin 01 N 220030827 FLAG + IDARUBICIN
220006700 220002577 0 78.9 Disease modification (D) 2016-11-23 2016-12-03 Nilotinib N N 220030838 NILOTINIB
220006701 220011489 1.64 60.6 Curative (C) 2016-03-25 2016-03-25 AML 19 TRIAL 01 N 220030840 AML19 TRIAL
220006702 220011489 1.75 76.7 Curative (C) 2017-06-17 2017-06-18 AML 19 TRIAL Y N 220030840 AML19 TRIAL
220006703 220002578 null null Disease modification (D) 2018-04-20 2018-04-25 Nilotinib N N 220030847 NILOTINIB
220006704 220002579 null null Disease modification (D) 2013-06-28 2013-07-02 Nilotinib N N 220030849 NILOTINIB
220006705 220002579 1.66 null Palliative (P) 2018-05-01 2018-07-20 Nilotinib 2 N 220030849 NILOTINIB
220006706 220002580 1.68 53.15 Curative (C) 2017-02-03 2017-02-03 AML 19 TRIAL Y N 220030858 AML19 TRIAL
220006707 220002580 null null Curative (C) 2016-07-24 2016-07-24 Nilotinib N N 220030858 NILOTINIB
220006708 220002580 null null Disease modification (D) 2016-07-03 2016-07-03 Nilotinib 2 N 220030858 NILOTINIB
220006709 220002580 1.79 0 Palliative (P) 2017-04-25 2017-04-29 Nilotinib N N 220030858 NILOTINIB
220006710 220002580 null null Disease modification (D) 2015-03-27 2015-03-30 Nilotinib N N 220030858 NILOTINIB
220006711 220002580 1.5 77 Curative (C) 2017-04-16 2017-04-16 AML 19 TRIAL Y N 220030858 AML19 TRIAL
220006712 220002580 1.5 118.9 Curative (C) 2014-12-02 2014-12-05 AML 19 TRIAL Y N 220030858 AML19 TRIAL